PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
mTOR Signaling and Cancer Progression
MAPK Signaling Cascades
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 20, 2026

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
Xiaoli Zheng1, Jing Cheng2, Manman Zhang2
1Department of Pharmacy, School of Medicine, Hangzhou City University, Hangzhou, Zhejiang, 310015, China; Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, Hangzhou city University, Hangzhou, 310015, China.
Thousand and one amino acid protein kinase 3 (TAOK3) drives clear cell renal cell carcinoma (ccRCC) progression by phosphorylating ASAP2. Targeting the TAOK3-ASAP2 pathway may offer new treatments for metastatic ccRCC.
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
07:38Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: